Eagle Bay Advisors LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eagle Bay Advisors LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$68,976
+30.9%
770
+24.4%
0.03%
+6.7%
Q2 2023$52,702
-6.1%
619
-8.7%
0.03%
-3.2%
Q1 2023$56,105
-9.9%
678
-14.4%
0.03%
-11.4%
Q4 2022$62,291
+29.8%
792
+23.6%
0.04%
+16.7%
Q3 2022$48,000
-99.9%
641
-1.8%
0.03%
+15.4%
Q2 2022$42,563,000
+265918.8%
653
+155.1%
0.03%
+100.0%
Q1 2022$16,000
-11.1%
256
-20.5%
0.01%
+18.2%
Q4 2021$18,000
+5.9%
322
+29.8%
0.01%
+10.0%
Q3 2021$17,000
-5.6%
248
+0.8%
0.01%
-28.6%
Q2 2021$18,0002460.01%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders